Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45520 | 24173291 | Gut | The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC? | 2013 | Details |
| A45521 | 24170694 | Diabetes | ITCH deficiency protects from diet-induced obesity. | 2013 | Details |
| A45522 | 24170613 | Clin Chem | Circulating fetuin-A and risk of ischemic stroke in women. | 2013 | Details |
| A45523 | 24165222 | Nurs Res | Using transient elastography to detect chronic liver diseases in a primary care nurse consultancy. | 2014 | Details |
| A45524 | 24143116 | Diabetes Metab Syndr Obes | Hepatic function and the cardiometabolic syndrome. | 2013 | Details |
| A45525 | 24134155 | Expert Rev Gastroenterol Hepatol | Milk thistle to treat non-alcoholic fatty liver disease: dream or reality? | 2013 | Details |
| A45526 | 24133662 | Clin Mol Hepatol | Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD. | 2013 | Details |
| A45527 | 24130602 | Hepat Mon | More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease. | 2013 | Details |
| A45528 | 24129500 | Eur J Nutr | Adiponectin receptor 1 enhances fatty acid metabolism and cell survival in palmitate-treated HepG2 cells through the PI3 K/AKT pathway. | 2013 | Details |
| A45529 | 24122898 | Hepatology | The hunt for treatment options of fatty liver continues: effects of retinoic acid on hepatic steatosis reveal novel transcriptional interactions of nuclear receptors. | 2014 | Details |
| A45530 | 24115630 | Liver Transpl | Is disease recurrence still relevant to graft survival? | 2013 | Details |
| A45531 | 24104204 | Physiol Genomics | Characterization of genome-wide transcriptional changes in liver and adipose tissues of ZDF (fa/fa) rats fed R-α-lipoic acid by next-generation sequencing. | 2013 | Details |
| A45532 | 24099290 | Methods Cell Biol | Analysis of lipid droplets in hepatocytes. | 2013 | Details |
| A45533 | 24095738 | Cell Rep | The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome. | 2013 | Details |
| A45534 | 26202033 | Hepatol Int | Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study. | 2013 | Details |
| A45535 | 24073302 | World J Hepatol | Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention. | 2013 | Details |
| A45536 | 24041073 | Rev Gastroenterol Mex | [Steatosis and non-alcoholic steatohepatitis]. | 2013 | Details |
| A45537 | 24065684 | Genet Mol Res | Association between the TRAIL single nucleotide polymorphism rs1131580 and type 2 diabetes mellitus in a Han Chinese population. | 2013 | Details |
| A45538 | 24065238 | Eur Rev Med Pharmacol Sci | Serum alpha-fetoprotein in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A45539 | 24062606 | J Clin Biochem Nutr | S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism. | 2013 | Details |
| A45540 | 24030551 | Arterioscler Thromb Vasc Biol | Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. | 2013 | Details |
| A45541 | 24026869 | Curr Diab Rep | What the genetics of lipodystrophy can teach us about insulin resistance and diabetes. | 2013 | Details |
| A45542 | 24026352 | Gut | Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals. | 2013 | Details |
| A45543 | 24005099 | Nihon Shokakibyo Gakkai Zasshi | [Genetic predisposition related to non-alcoholic fatty liver disease]. | 2013 | Details |
| A45544 | 24005067 | Praxis (Bern 1994) | [Fatty liver: frequent and not completely harmless]. | 2013 | Details |
| A45545 | 23999826 | Endocr Connect | Increased FGF21 plasma levels in humans with sepsis and SIRS. | 2013 | Details |
| A45546 | 23999684 | Indian J Gastroenterol | Cryptogenic cirrhosis is the leading cause for listing for liver transplantation in Sri Lanka. | 2013 | Details |
| A45547 | 23995473 | Diabetologia | Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. | 2013 | Details |
| A45548 | 23994032 | J Clin Anesth | Coronary artery disease and its risk factors in patients presenting for liver transplantation. | 2013 | Details |
| A45549 | 23973850 | Gastroenterology | NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials? | 2013 | Details |
| A45550 | 23970447 | Hum Exp Toxicol | Chunggan extract (CGX), methionine-and choline-deficient (MCD) diet-induced hepatosteatosis and oxidative stress in C57BL/6 mice. | 2013 | Details |
| A45551 | 23963894 | Diabetes Care | Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. | 2013 | Details |
| A45552 | 23959055 | Ann Surg Oncol | Evaluation of the usefulness of the indocyanine green clearance test for chemotherapy-associated liver injury in patients with colorectal cancer liver metastasis. | 2014 | Details |
| A45553 | 23958558 | Clin Gastroenterol Hepatol | Should we lower lipids in nonalcoholic fatty liver disease? | 2013 | Details |
| A45554 | 23954644 | Clin Gastroenterol Hepatol | Insulin resistance, obesity, and liver cancer. | 2013 | Details |
| A45555 | 23939612 | Am Fam Physician | Nonalcoholic fatty liver disease. | 2013 | Details |
| A45556 | 23929893 | Aging (Albany NY) | Lipid-induced hepatic insulin resistance. | 2013 | Details |
| A45557 | 23914059 | J Toxicol Pathol | Thioacetamide-induced Hepatocellular Necrosis Is Attenuated in Diet-induced Obese Mice. | 2013 | Details |
| A45558 | 23913480 | Hepatology | Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in obese adolescents: a looming marker of cardiac dysfunction. | 2013 | Details |
| A45559 | 23891611 | Gastroenterology | Do therapeutic bile acids hit the sweet spot of glucose metabolism in NAFLD? | 2013 | Details |
| A45560 | 23885358 | Curr Opin Clin Nutr Metab Care | Current world literature. Carbohydrates. | 2013 | Details |
| A45561 | 23885276 | Hepat Mon | Criteria to assess a randomized controlled pilot study: response to letter. | 2013 | Details |
| A45562 | 23878812 | Biomed Res Int | Molecular functions of thyroid hormones and their clinical significance in liver-related diseases. | 2013 | Details |
| A45563 | 23877532 | Nat Rev Gastroenterol Hepatol | Liver disease: Kupffer cells regulate the progression of ALD and NAFLD. | 2013 | Details |
| A45564 | 23871243 | Curr Biol | Cell-to-cell heterogeneity in lipid droplets suggests a mechanism to reduce lipotoxicity. | 2013 | Details |
| A45565 | 23861552 | J Lipid Res | Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36. | 2013 | Details |
| A45566 | 23855468 | Ann N Y Acad Sci | Resveratrol in metabolic health: an overview of the current evidence and perspectives. | 2013 | Details |
| A45567 | 23853344 | Orv Hetil | [Editor's commentary]. | 2013 | Details |
| A45568 | 23849766 | Gastroenterol Hepatol | [Agomelatine: fulminant liver failure in a patient with fatty liver]. | 2013 | Details |
| A45569 | 23847540 | Front Physiol | A new role for inflammasomes: sensing the disturbances in non-alcoholic fatty liver disease. | 2013 | Details |
| A45570 | 23843575 | J Pediatr Endocrinol Metab | Carotid intima media thickness and echocardiography in risk stratification of obese adolescents with non-alcoholic fatty liver disease: what is the "right" approach? | 2014 | Details |
| A45571 | 23840101 | Mediators Inflamm | Influence of gut microbiota on subclinical inflammation and insulin resistance. | 2013 | Details |
| A45572 | 23837135 | Clin Mol Hepatol | Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis. | 2013 | Details |
| A45573 | 23820123 | Clin Obstet Gynecol | Epidemic of obesity and metabolic syndrome. Foreword. | 2013 | Details |
| A45574 | 23816693 | Dig Liver Dis | Comment to "serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease". | 2013 | Details |
| A45575 | 23813872 | Hepatology | High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. | 2013 | Details |
| A45576 | 23811242 | Clin Gastroenterol Hepatol | Noninvasive methods of assessing nonalcoholic fatty liver disease: what the clinician needs to know. | 2013 | Details |
| A45577 | 23808468 | Arch Pathol Lab Med | Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India. | 2013 | Details |
| A45578 | 26201923 | Hepatol Int | Roles of alcohol drinking pattern in fatty liver in Japanese women. | 2013 | Details |
| A45579 | 23797065 | Horm Res Paediatr | Best determinants of nonalcoholic fatty liver disease and intra-abdominal fat in prepubertal children born small for gestational age: ultrasound technique versus anthropometric data. | 2013 | Details |
| A45580 | 23796632 | Horm Res Paediatr | Possible misinterpretations of nonalcoholic fatty liver disease and intra-abdominal fat in prepubertal children born small for gestational age. | 2013 | Details |
| A45581 | 23787943 | Hepatology | Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk? | 2013 | Details |
| A45582 | 23787705 | Hepatology | Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism. | 2013 | Details |
| A45583 | 30992848 | Clin Liver Dis (Hoboken) | Workup of nonalcoholic fatty liver disease. | 2013 | Details |
| A45584 | 23772495 | Nihon Naika Gakkai Zasshi | [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease]. | 2013 | Details |
| A45585 | 23770255 | J Hepatol | Focus. | 2013 | Details |
| A45586 | 23766126 | Endocrinology | Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. | 2013 | Details |
| A45587 | 23763554 | Expert Opin Ther Targets | Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease. | 2013 | Details |
| A45588 | 23762146 | Evid Based Complement Alternat Med | Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule. | 2013 | Details |
| A45589 | 23760388 | Indian J Med Res | Serum leptin levels correlate with body mass index but not with histologic disease severity in Indian patients with non-alcoholic steatohepatitis: a pilot study. | 2013 | Details |
| A45590 | 23744793 | Hepatology | Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis. | 2013 | Details |
| A45591 | 23744565 | Hepatology | Homeostatic generation of reactive oxygen species protects the zebrafish liver from steatosis. | 2013 | Details |
| A45592 | 23731091 | J Agric Food Chem | Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance. | 2013 | Details |
| A45593 | 23729294 | Hepatology | CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation. | 2013 | Details |
| A45594 | 27024624 | Johns Hopkins Med Lett Health After 50 | Nonalcoholic fatty liver disease: are you at risk? | 2013 | Details |
| A45595 | 26201792 | Hepatol Int | The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients. | 2012 | Details |
| A45596 | 26201767 | Hepatol Int | The BAFFling problem of B cell-activating factor in nonalcoholic fatty liver disease. | 2013 | Details |
| A45597 | 23720735 | J Biol Chem | C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis. | 2013 | Details |
| A45598 | 23720171 | Dtsch Med Wochenschr | [Diabetes and the liver]. | 2013 | Details |
| A45599 | 23715754 | Diabetes Care | Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects. | 2013 | Details |
| A45600 | 23715724 | Am J Physiol Endocrinol Metab | Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis. | 2013 | Details |
| A45601 | 23712496 | Mamm Genome | High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice. | 2013 | Details |
| A45602 | 23710178 | Int J Endocrinol | Major Histocompatibility Class II Pathway Is Not Required for the Development of Nonalcoholic Fatty Liver Disease in Mice. | 2013 | Details |
| A45603 | 23707460 | Clin Gastroenterol Hepatol | Common genetic variants and nonalcoholic Fatty liver disease. | 2013 | Details |
| A45604 | 23707366 | J Hepatol | Might some of the beneficial effects of the Mediterranean diet on non-alcoholic fatty liver disease be mediated by reduced iron stores? | 2013 | Details |
| A45605 | 23707363 | J Hepatol | Reply to: "might some of the beneficial effects of the Mediterranean diet on non-alcoholic fatty liver disease be mediated by reduced iron stores?". | 2013 | Details |
| A45606 | 23703836 | Hepatology | Finding the balance: the role of S-adenosylmethionine and phosphatidylcholine metabolism in development of nonalcoholic fatty liver disease. | 2013 | Details |
| A45607 | 23698242 | Med Sci Sports Exerc | Exercise reduces inflammation and oxidative stress in obesity-related liver diseases. | 2013 | Details |
| A45608 | 23696318 | Liver Transpl | Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. | 2013 | Details |
| A45609 | 23686813 | Hepatology | Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model. | 2013 | Details |
| A45610 | 23685558 | Arterioscler Thromb Vasc Biol | Hepatic steatosis is associated with aortic valve sclerosis in the general population: the Study of Health in Pomerania (SHIP). | 2013 | Details |
| A45611 | 23680744 | Hosp Pract (1995) | Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus. | 2013 | Details |
| A45612 | 23672630 | Curr Med Res Opin | Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients. | 2013 | Details |
| A45613 | 23656418 | Aliment Pharmacol Ther | Commentary: phlebotomy in non-alcoholic fatty liver disease. | 2013 | Details |
| A45614 | 23652472 | Curr Opin Lipidol | Emerging role of cellular cholesterol in the pathogenesis of nonalcoholic fatty liver disease. | 2013 | Details |
| A45615 | 23640498 | Arterioscler Thromb Vasc Biol | Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression. | 2013 | Details |
| A45616 | 23634669 | Diabetes Technol Ther | Has the time come for routine imaging studies in diabetes? | 2013 | Details |
| A45617 | 23632345 | J Clin Gastroenterol | Epidemiology of hepatocellular carcinoma: consider the population. | 2013 | Details |
| A45618 | 23628504 | Clin Gastroenterol Hepatol | Obese humans with nonalcoholic fatty liver disease display alterations in fecal microbiota and volatile organic compounds. | 2013 | Details |
| A45619 | 23627455 | Arch Pathol Lab Med | Increased thickness of abdominal subcutaneous adipose tissue occurs more frequently in steatohepatitis than in simple steatosis. | 2013 | Details |